Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.95 +0.08 (+4.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Polaryx Therapeutics (PLYX) Change in Accrued Expenses (2025)

Updated

Polaryx Therapeutics (PLYX) posted Change in Accured Expenses of -$66,000 for FY2025.

Analysis

Polaryx Therapeutics (PLYX) Change in Accrued Expenses (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Polaryx Therapeutics 93.21 Mn 68.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 8,000.00
Mar 31, 2025 -87,000.00
API Access

Polaryx Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PLYX&period=max&api_key=YOUR_API_KEY